Skip to search formSkip to main contentSkip to account menu

CEOP protocol

Known as: CEOP Regimen, Cyclophosphamide/Epirubicin/Vincristine/Prednisone 
National Institutes of Health

Related topics

Related topics

4 relations
CyclophosphamideEpirubicin HydrochloridePrednisoneVincristine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Dysfunctional neobladder causing pulmonary toxicity after combination chemotherapy for lymphoma
A 75-year-old man with transitional cell bladder carcinoma status post cystoprostatectomy with neobladder creation from the… 
2007
2007
[CEOP regimen in the treatment for non-Hodgkin's lymphoma].
OBJECTIVE The aim of this study is to analyse the efficacy and toxicity of CEOP regimen in the treatment of non-Hodgkin's… 
2005
2005
Workshop of the International Precipitation Working Group CLOUD PATCH-BASED RAINFALL ESTIMATION USING A SATELLITE IMAGE CLASSIFICATION APPROACH
The relationship between cloud and surface rain rate varies significantly from cloud patch to cloud patch. Therefore, a rainfall… 
2004
2004
Winter snow events over the Himalayas. Observations and simulations during CEOP EOP-3
The major mechanism responsible for wintertime snowfall events over the Himalayas is the strong dynamical interaction between the… 
1997
1997
Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin’s lymphoma (NHL). A multi…
Primary end point of this trial was to reduce neutropenic infections during the treatment of aggressive NHL with CEOP/IMVP-Dexa… 
1991
1991
POLICHEMIOTERAPIA ALTERNANTE CEOP/PEB NEI LINFOMI NON HODGKIN IN STADIO AVANZATO AD ISTOLOGIA SFAVOREVOLE
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)